Genetic landscape and clinical significance of cuproptosis-related genes in liver hepatocellular carcinoma

Documenti analoghi

• Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis
  di: Xinqiang Li, et al.
  Pubblicazione: (2022-11-01)
• Identification of cuproptosis-related subtypes, cuproptosis-related gene prognostic index in hepatocellular carcinoma
  di: Lei Ding, et al.
  Pubblicazione: (2022-09-01)
• Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma
  di: Xiaolong Tang, et al.
  Pubblicazione: (2023-01-01)
• DDR1 is a Novel Biomarker and Potential Therapeutic Target for the Combination Treatment of Liver Hepatocellular Carcinoma
  di: Tianxing Li, et al.
  Pubblicazione: (2024-09-01)
• Synergistic SDT/cuproptosis therapy for liver hepatocellular carcinoma: enhanced antitumor efficacy and specific mechanisms
  di: Yucao Sun, et al.
  Pubblicazione: (2024-12-01)